A randomized, double-blind, multicenter study to evaluate the tolerability and effectiveness of etoricoxib 90 mg q.d. vs diclofenac sodium 75 mg b.i.d in patients with rheumatoid arthritis.
Latest Information Update: 05 May 2022
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Acronyms EDGE II
- Sponsors Organon
- 01 Mar 2008 Gastrointestinal tolerability results published in the Annals of the Rheumatic Diseases 67: 315-322, No. 3, Mar 2008.
- 14 Nov 2006 Status change
- 27 Oct 2005 New trial record.